• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸放疗后 F 正电子发射断层扫描的心脏代谢变化可预测食管癌患者的总生存。

Cardiac metabolic changes on F-positron emission tomography after thoracic radiotherapy predict for overall survival in esophageal cancer patients.

机构信息

Department of Radiation Oncology, University of Washington, Seattle, Washington, USA.

Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA.

出版信息

J Appl Clin Med Phys. 2023 Sep;24(9):e13552. doi: 10.1002/acm2.13552. Epub 2022 Mar 4.

DOI:10.1002/acm2.13552
PMID:35243772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10476995/
Abstract

PURPOSE

Heart doses have been shown to be predictive of cardiac toxicity and overall survival (OS) for esophageal cancer patients. There is potential for functional imaging to provide valuable cardiac information. The purpose of this study was to evaluate the cardiac metabolic dose-response using F-deoxyglucose (FDG)-PET and to assess whether standard uptake value (SUV) changes in the heart were predictive of OS.

METHODS

Fifty-one patients with esophageal cancer treated with radiation who underwent pre- and post-treatment FDG-PET scans were retrospectively evaluated. Pre- and post-treatment PET-scans were rigidly registered to the planning CT for each patient. Pre-treatment to post-treatment absolute mean SUV (SUVmean) changes in the heart were calculated to assess dose-response. A dose-response curve was generated by binning each voxel in the heart into 10 Gy dose-bins and analyzing the SUVmean changes in each dose-bin. Multivariate cox proportional hazard models were used to assess whether pre-to-post treatment cardiac SUVmean changes predicted for OS.

RESULTS

The cardiac dose-response curve demonstrated a trend of increasing cardiac SUV changes as a function of dose with an average increase of 0.044 SUV for every 10 Gy dose bin. In multivariate analysis, disease stage and SUVmean change in the heart were predictive (p < 0.05) for OS.

CONCLUSIONS

Changes in pre- to post-treatment cardiac SUV were predictive of OS with patients having a higher pre- to post-treatment cardiac SUV change surviving longer.

摘要

目的

心脏剂量已被证明可预测食管癌患者的心脏毒性和总生存期(OS)。功能成像有可能提供有价值的心脏信息。本研究旨在评估使用 F-脱氧葡萄糖(FDG)-PET 的心脏代谢剂量反应,并评估心脏的标准摄取值(SUV)变化是否可预测 OS。

方法

回顾性评估了 51 名接受放射治疗的食管癌患者,这些患者在治疗前后均进行了 FDG-PET 扫描。对每位患者的治疗前后 PET 扫描进行了刚性注册,以与计划 CT 进行配准。计算心脏的治疗前后绝对平均 SUV(SUVmean)变化,以评估剂量反应。通过将心脏中的每个体素分为 10 Gy 剂量区,并分析每个剂量区的 SUVmean 变化,生成剂量反应曲线。多变量 Cox 比例风险模型用于评估治疗前后心脏 SUVmean 变化是否可预测 OS。

结果

心脏剂量反应曲线显示出随着剂量增加而心脏 SUV 变化增加的趋势,每个 10 Gy 剂量区的平均 SUV 增加了 0.044。在多变量分析中,疾病分期和心脏 SUVmean 变化是 OS 的预测因素(p < 0.05)。

结论

治疗前后心脏 SUV 的变化可预测 OS,心脏 SUV 变化较大的患者生存期较长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/aa75f8d3fb4c/ACM2-24-e13552-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/b631126625e2/ACM2-24-e13552-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/c5d69b15d8fd/ACM2-24-e13552-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/aa75f8d3fb4c/ACM2-24-e13552-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/b631126625e2/ACM2-24-e13552-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/c5d69b15d8fd/ACM2-24-e13552-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1805/10476995/aa75f8d3fb4c/ACM2-24-e13552-g003.jpg

相似文献

1
Cardiac metabolic changes on F-positron emission tomography after thoracic radiotherapy predict for overall survival in esophageal cancer patients.胸放疗后 F 正电子发射断层扫描的心脏代谢变化可预测食管癌患者的总生存。
J Appl Clin Med Phys. 2023 Sep;24(9):e13552. doi: 10.1002/acm2.13552. Epub 2022 Mar 4.
2
Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer.评估肺癌患者化疗-放疗后心脏正电子发射断层扫描(PET)功能成像的变化。
Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1063-1070. doi: 10.1016/j.ijrobp.2019.12.013. Epub 2020 Jan 23.
3
Prognostic values of mid-radiotherapy F-FDG PET/CT in patients with esophageal cancer.放疗中程 18F-FDG PET/CT 预测食管癌患者预后的价值。
Radiat Oncol. 2019 Feb 4;14(1):27. doi: 10.1186/s13014-019-1232-1.
4
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.¹⁸F-FDG-PET 影像学特征预测食管癌新辅助放化疗病理反应。
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1375-82. doi: 10.1016/j.ijrobp.2012.10.017. Epub 2012 Dec 6.
5
Correlation of molecular response as measured by 18-FDG positron emission tomography with outcome after chemoradiotherapy in patients with esophageal carcinoma.18-FDG正电子发射断层扫描测量的分子反应与食管癌患者放化疗后预后的相关性。
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):358-63. doi: 10.1016/j.ijrobp.2007.03.053. Epub 2007 May 29.
6
The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer.(18)F-氟脱氧葡萄糖正电子发射断层扫描在预测可手术食管癌患者生存率中的临床应用。
Cancer. 2009 Jul 15;115(14):3196-203. doi: 10.1002/cncr.24399.
7
The role of qualitative and quantitative analysis of F18-FDG positron emission tomography in predicting pathologic response following chemoradiotherapy in patients with esophageal carcinoma.F18-FDG正电子发射断层扫描的定性和定量分析在预测食管癌患者放化疗后病理反应中的作用。
J Gastrointest Cancer. 2012 Dec;43(4):612-8. doi: 10.1007/s12029-012-9412-3.
8
[(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.[(18)F]FDG-PET 标准摄取值作为预测骨髓对放化疗反应的代谢指标:对接受放化疗的宫颈癌患者急性和晚期血液学毒性的影响。
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1099-107. doi: 10.1016/j.ijrobp.2014.08.017. Epub 2014 Oct 13.
9
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.放化疗后正电子发射断层扫描预测食管癌患者的病理反应和生存。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):471-7. doi: 10.1016/j.ijrobp.2011.12.029. Epub 2012 Feb 28.
10
Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.证实术前肿瘤 SUR 和 MTV 对食管鳞癌患者的预后价值。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1485-1494. doi: 10.1007/s00259-019-04307-6. Epub 2019 Apr 4.

引用本文的文献

1
Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy.新型功能放射组学预测肺癌放疗中心脏正电子发射断层扫描摄取率。
JCO Clin Cancer Inform. 2024 Mar;8:e2300241. doi: 10.1200/CCI.23.00241.
2
Nuclear medicine imaging methods of early radiation-induced cardiotoxicity: a ten-year systematic review.早期放射性心脏毒性的核医学成像方法:一项十年系统综述
Front Oncol. 2023 Oct 9;13:1240889. doi: 10.3389/fonc.2023.1240889. eCollection 2023.
3
Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy.

本文引用的文献

1
Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer.评估肺癌患者化疗-放疗后心脏正电子发射断层扫描(PET)功能成像的变化。
Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1063-1070. doi: 10.1016/j.ijrobp.2019.12.013. Epub 2020 Jan 23.
2
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.食管和胃食管交界处癌,2019 年第 2 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Jul 1;17(7):855-883. doi: 10.6004/jnccn.2019.0033.
3
The Expanding Role of Physiologic Imaging in Radiation Oncology.
血液参数和正常组织剂量对接受新辅助放化疗的食管癌患者治疗结果的影响
Cancers (Basel). 2022 Jul 19;14(14):3504. doi: 10.3390/cancers14143504.
生理成像在放射肿瘤学中不断扩大的作用。
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):694-697. doi: 10.1016/j.ijrobp.2018.01.059. Epub 2018 Jun 19.
4
O-HO PET/CT as a tool for the quantitative assessment of early post-radiotherapy changes of heart perfusion in breast carcinoma patients.O-HO PET/CT 作为一种工具,用于定量评估乳腺癌患者放疗后早期心脏灌注变化。
Br J Radiol. 2018 Jul;91(1088):20170653. doi: 10.1259/bjr.20170653. Epub 2018 Jul 20.
5
Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.肝脏肿瘤立体定向体部放射治疗后的局部控制。
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):188-195. doi: 10.1016/j.ijrobp.2017.12.288. Epub 2018 Jan 6.
6
F-FDG PET image biomarkers improve prediction of late radiation-induced xerostomia.18F-FDG PET 图像生物标志物可改善晚期放射性口干的预测。
Radiother Oncol. 2018 Jan;126(1):89-95. doi: 10.1016/j.radonc.2017.08.024. Epub 2017 Sep 23.
7
Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.在接受质子束治疗或调强放射治疗的大批次食管癌患者中,对心脏和心脏亚结构的剂量学比较。
Radiother Oncol. 2017 Oct;125(1):48-54. doi: 10.1016/j.radonc.2017.07.034. Epub 2017 Sep 13.
8
Radiation-Induced Cardiomyopathy Incidentally Detected on Oncology F-Fluorodeoxyglucose Positron Emission Tomography.肿瘤学氟代脱氧葡萄糖正电子发射断层扫描偶然发现的放射性心肌病
Circ J. 2018 Mar 23;82(4):1210-1212. doi: 10.1253/circj.CJ-17-0466. Epub 2017 Aug 18.
9
Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients.在I-II期非小细胞肺癌患者中,立体定向体部放疗后心脏亚结构所受剂量与非癌症死亡相关。
Radiother Oncol. 2017 Jun;123(3):370-375. doi: 10.1016/j.radonc.2017.04.017. Epub 2017 May 2.
10
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.调强放射治疗技术对局部晚期非小细胞肺癌的影响:NRG肿瘤学RTOG 0617随机临床试验的二次分析
J Clin Oncol. 2017 Jan;35(1):56-62. doi: 10.1200/JCO.2016.69.1378. Epub 2016 Oct 31.